Dr. Hashmi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Summary
- Dr. Shahrukh Hashmi is an oncologist in Rochester, MN and is affiliated with Mayo Clinic Hospital - Rochester. He received his medical degree from Baqai University, and has been in practice 17 years. He received his Master's degree from the Yale University. He specializes in hematologic oncology and is experienced in GVHD, CAR-T cells, hematologic malignancies, cancer survivorship, and hematopoietic stem cell transplantation.
Education & Training
University of RochesterFellowship, Hematology and Medical Oncology, 2009 - 2012
Griffin HospitalResidency, Internal Medicine, 2003 - 2006
Baqai Medical and Dental CollegeClass of 2000
Yale UniversityMPH, Epidemiology
Certifications & Licensure
MN State Medical License 2012 - 2024
CT State Medical License 2006 - 2009
Clinical Trials
- Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE) Start of enrollment: 2014 Aug 29
- Tocilizumab for Chronic Graft-versus-Host Disease Treatment Start of enrollment: 2016 Feb 01
- Comparing Post-Transplant Cyclophosphamide as GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients Start of enrollment: 2021 Aug 15
Publications & Presentations
PubMed
- Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis.Abid, M. B., Hemant S Murthy, Mei-Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly, Ankit Kansagra, Fotios V Michelis, Taiga Nishihori, Mrinal Pat...> ;Blood Advances. 2023 Nov 28
- A personalized, organ-based approach to the treatment of chronic steroid-refractory graft-versus-host disease.Fatoum, H., Zeiser, R., Hashmi, S.> ;Blood Reviews. 2024 Jan 1
- Machine learning applications and challenges in graft-versus-host disease: a scoping review.Areez Shafqat, Haneen T Salah, Shahrukh K Hashmi, Ibrahim N Muhsen, Ali Hassan Mushtaq> ;Current Opinion in Oncology. 2023 Nov 1
- Join now to see all
Journal Articles
- Review Vaccinating Donors for Hematopoietic Cell Transplantation: A Systematic Review and Future PerspectivesShahrukh K Hashmi, John R Wingard, ScienceDirect
- Does Matching for SNPs in the MHC Gamma Block in 10/10 HLA-Matched Unrelated Donor-Recipient Pairs Undergoing Allogeneic Stem Cell Transplant Improve Outcomes?Eapen K Jacob, Shahrukh K Hashmi, Justin D Kreuter, William J Hogan, Dennis A Gastineau, Ann M Moyer, Mark Litzow, ScienceDirect
Lectures
- Lost to Follow-up Rates Are Higher in Pediatric Than Adult Survivors, but Not By Transplant Type: A Report from the Center for International Blood and Marrow Transplan...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Phase II of Combination Daunorubicin and Cytarabine (Ara-c) and Nilotinib (TAsigna) (DATA) in Patients Newly Diagnosed with Acute Myeloid Leukemia and KIT Expression...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Gene Therapy for Thalassemia and Sickle Cell Anemia Poses Acceptable Toxicity and Efficacy: Clinical Outcomes in Forty-Seven Cases2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Risk of Cancer-Specific Death May Remain Elevated for 30 YearsMay 6th, 2022- Sheikh Shakhbout Medical City Focuses on Holistic Care This Breast Cancer Awareness MonthOctober 9th, 2021
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
